Skip to main content
. 2016 Nov 23;10(1):1–9. doi: 10.1016/j.tranon.2016.10.004

Table 2.

Cox regression analyses for contribution of various potential prognostic factors to survival in BC patients.

Variable factors Disease-free survival HR(95%CI) P value Overall survival HR(95%CI) P value Metastasis-free survival HR(95%CI) P value
Univariate analysis
 RFC3 expression (high vs low) 4.484 (1.695-13.864) .003 4.154 (1.889-9.136) <.001 14.515 (4.985-42.263) <.001
 Age (≥49 vs <49) 1.016 (0.975-1.059) .455 1.006 (0.974-1.040) .708 0.997 (0.965-1.029) .843
 Tumor size (≥2 cm vs <2 cm) 2.770 (1.294-5.927) .009 2.535 (1.081-5.943) .032 3.168 (1.455-6.899) .004
 Nodel status (positive vs negative) 3.732 (1.921-7.250) <.001 3.313 (1.617-6.788) <.001 4.138 (2.038-8.042) <.001
 Ki67 expression (positive vs negative) 0.996 (0.460-2.154) .991 0.945 (0.408-2.191) .896 1.105 (0.485-2.522) .812
 Histologic grade (I/II vs III) 0.821 (0.408-1.651) .58 1.186 (0.572-2.460) .646 0.758 (0.358-1.604) .468
Multivariate analysis
 RFC3 expression (high vs. low) 11.646 (4.772-28.420) <.001 5.037 (2.184-11.622) <.001 20.429 (6.743-61.892) <.001
 Tumor size (≥2 cm vs <2 cm) 1.346 (0.414-4.373) .622 0.839 (0.319-2.207) .722 1.051 (0.409-2.699) .918
 Nodel status (positive vs negative) 7.265 (3.154-16.738) .000 3.444 (1.365-8.687) .009 8.773 (3.552-21.669) <.001

Analysis was conducted on 127 cases. HRs (95% CI) and P values were calculated using univariate or multivariate Cox proportional hazard regression.